CDK7-IN-11
CDK7-IN-11 is an orally active CDK7 inhibitor. CDK7-IN-11 exhibits high CDK7 inhibitory activity with IC50 value of 4.2 nM. CDK7-IN-11 can be effectively used for the research of diseases associated with CDK7[1].
Product Specifications
CAS Number
[2414896-32-3]
UNSPSC
12352005
Target
CDK
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/cdk7-in-11.html
Solubility
10 mM in DMSO
Smiles
N#CC1=CC(C2=CC([C@H](C)C(NC3=NC=C(CC)S3)=O)=CC=C2)=CN=C1NC(/C=C/CN(C)C)=O
Molecular Formula
C26H28N6O2S
Molecular Weight
488.60
References & Citations
[1]Novel cdk7 inhibitory compound or pharmaceutically acceptable salt thereof. Patent. WO2021182914A1.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CDK7
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
588786 50 µg
TRA (TCRA, TCRD, TRA, T-cell antigen receptor, alpha polypeptide, T-cell receptor, alpha (V, D, J, C) )
Ask
View Details